December 10th, 2010
It has been a difficult year for diet drugs. October saw the Food and Drug Administration banning two weight loss-drugs, lorcaserin and Qnexa, due to possible links with cancer and heart problems. However, this week an FDA panel gave the approval for a new drug, Contrave, in the fight against ...